|
EXECUTIVE BIOGRAPHIES
Bren Collinson
Managing Director and CEO
Founder and CEO Bren Collinson has more than 30 years experience in the Science Industry starting his career as a Research Technician and Analytical Chemist in New Zealand in the early 1970’s and moving into Sales and Marketing in the mid 1980’s with a well known New Zealand distribution company. In 1991 Bren moved his family to Melbourne, Australia to establish the Australasian sales operation for Molecular Dynamics (Sunnyvale, CA) and continued to grow that business until the merger of Molecular Dynamics with Amersham in 1998. Bren remained with Amersham as the Australasian Sales Manager for 12 months until moving on to establish Millennium Science in April 1999. Under his leadership Millennium Science has experienced consistent revenue growth to become one of the most respected distributors of high technology systems for Life Science research in Australasia.
Richard Holder
Executive Director, Operations and Engineering Services
COO Richard Holder has accumulated 25 years experience in electronics and instrumentation in both the Government and Private sectors. In 1980 Richard enlisted in the Royal Australian Navy and studied electronics. After graduating he served on several ships operating in international waters, maintaining and operating the navigation and ship-based weapons systems. After resigning from the Navy in 1990 Richard accepted a position as a Field Service Engineer for an Australian distributor of medical / scientific equipment. In 1997 Richard formed Advanced Labs and Automated Laboratory Technologies (ALT). In January 2005, Automated Laboratory Technologies was acquired by Millennium Science as a growth strategy to provide comprehensive automation solutions to the research sector. With over 15 years in the science industry, Richard Holder has a strong background in instrument service engineering and project management.
Robert Henke, PhD
Life Sciences Sales Director and Chief Scientific Officer
Robert Henke received his PhD in Biology from the University of Sydney in 1998 for a thesis exploring the signal transduction mechanisms of GPI-anchored proteins in the nervous system. Following the completion of his PhD, Robert joined Amersham Life Sciences, where he ran applications support for 2 years. In 2000, Robert joined Millennium Science as an applications specialist for Affymetrix technology. He has since gained significant experience in developing microarray-based applications in expression, genotyping, and re-sequencing of DNA using the Affymetrix technology. Robert was appointed to his current position in 2006, which involves advising on the evaluation and selection of commercial technologies relevant to the Australia and New Zealand life science markets, as well as managing sales activities and applications support across Australia and New Zealand.
|
